SciVision Biotech Inc (1786) — Capital Reinvestment Ratio
SciVision Biotech Inc (1786) has a Capital Reinvestment Ratio of 2.11x as of September 2025, meaning it reinvests 2% of its operating cash flow (NT$15.41 Million) in capital expenditures (NT$32.58 Million). See SciVision Biotech Inc net asset quality index to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
SciVision Biotech Inc Capital Reinvestment Ratio (2010–2025)
This chart tracks SciVision Biotech Inc's Capital Reinvestment Ratio across 16 annual periods. Check how aggressively does SciVision Biotech Inc reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for SciVision Biotech Inc (2010–2025)
Year-by-year Capital Reinvestment Ratio for SciVision Biotech Inc from 2010 to 2025. For live market cap and broader valuation context, see market cap of SciVision Biotech Inc.
| Year | Reinvestment Ratio | Operating CF (TWD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.82x | NT$123.99 Million | NT$101.53 Million | ▲ +533.5% |
| 2024 | 0.13x | NT$269.87 Million | NT$34.88 Million | ▲ +136.8% |
| 2023 | 0.05x | NT$272.01 Million | NT$14.84 Million | ▼ -35.0% |
| 2022 | 0.08x | NT$178.21 Million | NT$14.96 Million | ▼ -67.9% |
| 2021 | 0.26x | NT$98.51 Million | NT$25.77 Million | ▼ -50.5% |
| 2020 | 0.53x | NT$126.47 Million | NT$66.84 Million | ▼ -46.5% |
| 2019 | 0.99x | NT$204.40 Million | NT$202.03 Million | ▲ +15.8% |
| 2018 | 0.85x | NT$111.70 Million | NT$95.32 Million | ▼ -95.8% |
| 2017 | 20.29x | NT$15.98 Million | NT$324.26 Million | ▲ +237.3% |
| 2016 | 6.02x | NT$38.29 Million | NT$230.32 Million | ▲ +46.0% |
| 2015 | 4.12x | NT$49.81 Million | NT$205.27 Million | ▼ -94.0% |
| 2014 | 68.18x | NT$1.85 Million | NT$126.27 Million | ▲ +9062.9% |
| 2013 | 0.74x | NT$37.27 Million | NT$27.74 Million | ▲ +182.3% |
| 2012 | 0.26x | NT$51.52 Million | NT$13.58 Million | ▼ -53.2% |
| 2011 | 0.56x | NT$37.13 Million | NT$20.91 Million | ▼ -83.3% |
| 2010 | 3.38x | NT$6.85 Million | NT$23.13 Million | — |